Primary Immunodeficiency Disease News

There are more than 450 monogenetic immune deficiencies. While many of these rare conditions have similar hallmarks, it is crucial for clinicians to differentiate between them.

Healio compiled the most-read news in allergy, asthma and immunology posted in May.

Healio has compiled April’s most-read news in asthma and allergy.

The FDA has approved mavorixafor for treating warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome, a rare and chronic primary immunodeficiency, according to a press release from X4 Pharmaceuticals.

The effects of climate change break down epithelial barriers, enabling pollutants and other materials to penetrate the body and trigger or exacerbate autoimmune diseases, according to a review published in Frontiers in Science.

WASHINGTON — Genetic testing can provide answers about children who may have primary immunodeficiencies when antibody and cell testing meet their limits, according to a speaker at the Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Genetic testing has increased the number of patients diagnosed with primary immunodeficiencies, Eveline Wu, MD, MSCR, told Healio during the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Children with primary immunodeficiencies should receive routine inactive vaccinations and other prophylactic treatment, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Whole-exome sequencing helped physicians identify undiagnosed primary immunodeficiency diseases in children with community-acquired sepsis, according to a study published in Pediatric Allergy and Immunology.